Journal of Clinical Endocrinology & Metabolism, Vol 81, 4329-4333, Copyright © 1996 by Endocrine Society

ARTICLES

Growth hormone increases interleukin-6 produced by human osteoblast- like cells

D Swolin and C Ohlsson
Department of Internal Medicine, Sahlgrenska Hospital, University of Goteborg, Sweden.

Physiological levels of GH are necessary for normal bone remodeling. GH treatment increases bone resorption and results in enhanced bone formation. The aim of the present study was to investigate whether the GH-induced increase in bone resorption could be mediated by a regulation of interleukin-6 (IL-6) production by human osteoblast-like cells. Cultures of human osteoblast-like cells were established from trabecular bone. Ribonuclease protection analysis demonstrated a high expression of the IL-6 messenger ribonucleic acid (mRNA) transcript in osteoblast-like cells, bone, and muscle, whereas expression was lower in liver. GH increased IL-6 mRNA levels as well as IL-6 protein released into the culture medium from human osteoblast-like cells in a time- and dose-dependent manner, with a maximal effect at 100 micrograms/L (mRNA, 322 +/- 95% of control; protein, 576 +/- 155% of control). In conclusion, GH increases IL-6 produced by human osteoblast- like cells. This in vitro evidence suggests, for the first time, a mechanistic paradigm by which GH modulates bone resorption.

This article has been cited by other articles:

				X. Q. Xu, B. S. Emerald, E. L. K. Goh, N. Kannan, L. D. Miller, P. D. Gluckman, E. T. Liu, and P. E. Lobie Gene Expression Profiling to Identify Oncogenic Determinants of Autocrine Human Growth Hormone in Human Mammary Carcinoma J. Biol. Chem., June 24, 2005; 280(25): 23987 - 24003. [Abstract] [Full Text] [PDF]

				T. Ueland GH/IGF-I and bone resorption in vivo and in vitro Eur. J. Endocrinol., March 1, 2005; 152(3): 327 - 332. [Abstract] [Full Text] [PDF]

				A. G. Holmes, M. J. Watt, and M. A. Febbraio Suppressing lipolysis increases interleukin-6 at rest and during prolonged moderate-intensity exercise in humans J Appl Physiol, August 1, 2004; 97(2): 689 - 696. [Abstract] [Full Text] [PDF]

				P. Prolo, F. Chiappelli, G. Bernard, M. Fiala, A. Ibarra, M.L. Sartori, A. Dovio, and A. Angeli Neuroendocrine-Immune Surveillance of Osteosarcoma: Emerging Hypothesis Journal of Dental Research, June 1, 2003; 82(6): 417 - 421. [Abstract] [Full Text] [PDF]

				R. Graichen, D. Liu, Y. Sun, K.-O. Lee, and P. E. Lobie Autocrine Human Growth Hormone Inhibits Placental Transforming Growth Factor-beta Gene Transcription to Prevent Apoptosis and Allow Cell Cycle Progression of Human Mammary Carcinoma Cells J. Biol. Chem., July 12, 2002; 277(29): 26662 - 26672. [Abstract] [Full Text] [PDF]

				T. Ueland, J. Bollerslev, A. Flyvbjerg, T. B. Hansen, N. Vahl, and L. Mosekilde Effects of 12 Months of GH Treatment on Cortical and Trabecular Bone Content of IGFs and OPG in Adults with Acquired GH Deficiency: A Double-Blind, Randomized, Placebo-Controlled Study J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2760 - 2763. [Abstract] [Full Text] [PDF]

				D. Le Roith, C. Bondy, S. Yakar, J.-L. Liu, and A. Butler The Somatomedin Hypothesis: 2001 Endocr. Rev., February 1, 2001; 22(1): 53 - 74. [Abstract] [Full Text]

				A. Frost, K. B. Jonsson, H. Brändström, C. Ohlsson, S. Ljunghall, and O. Ljunggren Interleukin-13 Inhibits Cell Proliferation and Stimulates Interleukin-6 Formation in Isolated Human Osteoblasts J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3285 - 3289. [Abstract] [Full Text]

				C. Ohlsson, B.-A. Bengtsson, O. G. P. Isaksson, T. T. Andreassen, and M. C. Slootweg Growth Hormone and Bone Endocr. Rev., February 1, 1998; 19(1): 55 - 79. [Abstract] [Full Text]

				N. Franchimont, V. Gangji, D. Durant, and E. Canalis Interleukin-6 with Its Soluble Receptor Enhances the Expression of Insulin-Like Growth Factor-I in Osteoblasts Endocrinology, December 1, 1997; 138(12): 5248 - 5255. [Abstract] [Full Text] [PDF]